BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23861892)

  • 1. Atg4b-dependent autophagic flux alleviates Huntington's disease progression.
    Proenca CC; Stoehr N; Bernhard M; Seger S; Genoud C; Roscic A; Paganetti P; Liu S; Murphy LO; Kuhn R; Bouwmeester T; Galimberti I
    PLoS One; 2013; 8(7):e68357. PubMed ID: 23861892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease.
    Ramírez-Jarquín UN; Sharma M; Zhou W; Shahani N; Subramaniam S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35086928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
    Lee CY; Cantle JP; Yang XW
    FEBS J; 2013 Sep; 280(18):4382-94. PubMed ID: 23829302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD.
    Singer E; Walter C; Fabbro D; Rageot D; Beaufils F; Wymann MP; Rischert N; Riess O; Hillmann P; Nguyen HP
    Neuropharmacology; 2020 Jan; 162():107812. PubMed ID: 31622602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.
    Fusco FR; Chen Q; Lamoreaux WJ; Figueredo-Cardenas G; Jiao Y; Coffman JA; Surmeier DJ; Honig MG; Carlock LR; Reiner A
    J Neurosci; 1999 Feb; 19(4):1189-202. PubMed ID: 9952397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.
    Kim C; Yousefian-Jazi A; Choi SH; Chang I; Lee J; Ryu H
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.
    Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR
    J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.
    Creus-Muncunill J; Rué L; Alcalá-Vida R; Badillos-Rodríguez R; Romaní-Aumedes J; Marco S; Alberch J; Perez-Otaño I; Malagelada C; Pérez-Navarro E
    Mol Neurobiol; 2018 Oct; 55(10):7728-7742. PubMed ID: 29460266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
    Fu Y; Sun X; Lu B
    Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse.
    Chopra V; Fox JH; Lieberman G; Dorsey K; Matson W; Waldmeier P; Housman DE; Kazantsev A; Young AB; Hersch S
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16685-9. PubMed ID: 17925440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
    Martín-Aparicio E; Yamamoto A; Hernández F; Hen R; Avila J; Lucas JJ
    J Neurosci; 2001 Nov; 21(22):8772-81. PubMed ID: 11698589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bim contributes to the progression of Huntington's disease-associated phenotypes.
    Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S
    Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.
    Bailus BJ; Scheeler SM; Simons J; Sanchez MA; Tshilenge KT; Creus-Muncunill J; Naphade S; Lopez-Ramirez A; Zhang N; Lakshika Madushani K; Moroz S; Loureiro A; Schreiber KH; Hausch F; Kennedy BK; Ehrlich ME; Ellerby LM
    Autophagy; 2021 Dec; 17(12):4119-4140. PubMed ID: 34024231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.